FDA Proposes to Withdraw Approval of Four New Drug Applications

Summary

The Food and Drug Administration (FDA) is inviting public input on its plan to revoke the approval of four new prescription drug applications (NDAs) submitted by pharmaceutical companies, citing repeated failure to submit required annual reports. The FDA is seeking public comment on this proposal.